An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer

NCT03413956 | Completed

• 1 other identifier: JS-LC-01
• Study Type: observational
• Target: 10,885
• Locations: 1 country
• Sites: 10

Brief Summary

The real-world observational study was designed to explore the odd factors of lymph metastases in the patients with T1 non-small cell lung cancer, the effects of clinical characteristics on lymph metastases, and compare the differences in lymph metastases in the subgroups.

Conditions

Non Small Cell Lung Cancer

Keywords

Chinese; T1 non-small cell lung cancer; Lymph metastases

Outcome Measures

Primary Outcomes (1)

• Percentage of the patients with lymph metastases

  Percentages of the patients with lymph metastases categorised by patient demographic and tumor biological characteristics

  2015 - 2017

Secondary Outcomes (1)

• Percentages of N0/N1/N2/N3 patients

  2015 - 2017

Other Outcomes (4)

• Percentage of N2 patients with lymph nodes

  2015 - 2017

• Percentage of patients with lymph metastases categorised by tumor baseline characteristics

  2015 - 2017

• Number of lymph nodes in N2 patients

  2015 - 2017

Study Arms (1)

NSCLC patients with lymph metastases

Pathologically diagnosed patients with T1 non-small cell lung cancer complicated with lymph metastases after surgeries

Procedure: Surgeries

Interventions

Surgeries PROCEDURE

Surgeries

NSCLC patients with lymph metastases

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The eligible subjects are the Chinese T1 patients with non-small cell lung cancer complicated with lymph metastases

You may qualify if:

• Patients who received surgeries from 2015 to 2017;
• Pathologically diagnosed patients with T1 non-small cell lung cancer;

You may not qualify if:

• \- Patients with tumor treatments (including chemotherapies, radiotherapies, biological therapies, intervention therapies)

Sponsors & Collaborators

• Jiangsu Cancer Institute & Hospital: lead

Study Sites (10)

China-Japan Friendship Hospital

Beijing, Beijing Municipality, 100029, China

Location

China People's Liberation Army Hospital

Beijing, Beijing Municipality, 100853, China

Location

Henan cancer hospital

Zhengzhou, Henan, 450003, China

Location

Henan Cancer Hospital

Zhengzhou, Henan, China

Location

Tongji Hospital Affiliated to Tongji Medical College, Huaxi Technology University

Wuhan, Hubei, 430030, China

Location

Jiangsu Cancer Institute and Hospital

Nanjing, Jiangsu, 210009, China

Location

Xi'an Tangdu Hospital

Xi'an, Shaanxi, 710000, China

Location

Shanghai Chest Hospital

Shanghai, Shanghai Municipality, 200030, China

Location

West China Hospital

Chengdu, Sichuan, 610041, China

Location

First Hospital Affiliated to Medical College, Zhejiang University

Hangzhou, Zhejiang, 310006, China

Location

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Carcinoma, Bronchogenic; Bronchial Neoplasms; Lung Neoplasms; Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Lin Xu

  Jiangsu Cancer Institute and Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate professor

Study Record Dates

• First Submitted: January 15, 2018
• First Posted: January 29, 2018
• Study Start: December 1, 2017
• Primary Completion: March 30, 2018
• Study Completion: March 30, 2018
• Last Updated: May 21, 2018

Record last verified: 2018-05

Data Sharing

• IPD Sharing: Will not share

Locations

CN (10)